1. France Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
EssilorLuxottica S.A.

EssilorLuxottica S.A.

EL.PA
EssilorLuxottica S.A.undefined flagEuronext Paris
175.55
EUR
+2.95
- -
80.68BMarket Cap
EssilorLuxottica S.A.
EL.PA
(Euronext Paris)

Recent

price

175.55

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
18.57
20.22
23.96
24.1
26.93
31.65
33.15
41.64
41.56
40.06
33.1
45.17
55.41
56.68
58.4
62.07
Revenue per Share
2.25
2.44
2.8
2.82
4.41
3.57
3.79
4.72
4.15
2.48
0.2
3.3
4.87
5.11
5.2
5.04
Basic EPS, GAAP
2.29
2.23
4.03
4.01
4.9
4.09
5.56
7.27
9.05
5.52
5.28
8.01
7.26
7.43
7.38
8.2
Free Cash Flow per Basic Share
0.7
0.83
0.85
0.89
0.94
1.02
0.37
2
1.86
2.04
1.15
0.31
1.03
1.09
2.56
1.19
Dividend per Share
13.51
15.31
17.08
18.9
22.45
24.68
26.97
4.9
4.45
2.66
0.38
3.48
5.05
5.29
5.38
5.22
Book Value per Share
4.87
4.79
5.79
3.96
-4.47
-4.85
-4.48
4.35
-7.89
-0.1
0.25
-13.28
-10.65
-5.33
-4.51
-2.77
Tangible Book Value per Share
210
207
208
210
211
212
215
221
261
434
436
439
442
448
454
459
Basic Weighted Avg Shares
3,892
4,190
4,989
5,065
5,670
6,716
7,115
9,184
10,835
17,390
14,429
19,820
24,494
25,395
26,508
28,491
Sales/Revenue/Turnover
16.87
16.9
16.84
17.51
17.58
18.31
17.92
14.11
12.93
9.51
3.17
11.65
12.88
12.52
13
11.85
Operating Margin (%)
180
181
230
247
451
380
360
541
1,219
2,121
2,155
2,387
2,921
2,972
3,049
3,090
Depreciation Expense
472
506
584
593
929
757
813
1,040
1,083
1,077
85
1,448
2,152
2,289
2,359
2,315
Net Income, GAAP
26.18
25.72
24.73
23.55
16.37
27.48
24.46
17.1
10.78
22.82
52.4
26.69
24.77
20.07
24.31
23.54
Effective Tax Rate (%)
12.13
12.07
11.71
11.71
16.38
11.27
11.43
11.32
10
6.19
0.59
7.31
8.79
9.01
8.9
8.13
Profit Margin (%)
564
502
952
993
212
419
-209
1,082
-466
5,133
7,550
602
752
1,279
966
1,108
Working Capital
286
309
526
607
1,521
1,905
1,364
1,672
4,045
8,483
10,735
11,409
11,194
10,258
9,804
10,715
LT Debt
3,044
3,458
3,914
4,041
5,260
6,092
7,054
5,814
33,403
35,332
32,798
35,875
38,147
38,892
41,002
39,493
Total Equity
14.01
12.54
12.99
12.79
12.34
10.46
10.14
11.86
5.19
2.96
0.47
3.49
4.6
4.86
4.88
4.68
Return on Invested Capital (%)
16.1
12.93
12.42
11.02
14.1
9.57
9.43
18.97
21.67
11.92
0.74
10.03
14.05
15.06
16.42
15.08
Return on Capital (%)
18.96
16.84
17.35
15.75
21.36
15.2
14.75
30.29
96.7
93.01
12.88
171.16
114.44
99.44
98.05
95.68
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
49.07%
3.88%
-3.68%
Free Cash Flow
17.75%
12.14%
12.35%
Net Income, GAAP
160.65%
331.94%
-1.87%
Sales/Revenue/Turnover
17.29%
15.3%
7.48%
Total Cash Common Dividend
69.3%
49.91%
-52.97%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
25,395
2024
- -
- -
- -
- -
26,508
2025
- -
- -
- -
- -
28,491

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
5.11
2024
- -
- -
- -
- -
5.2
2025
- -
- -
- -
- -
5.04

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.09
2024
- -
- -
- -
- -
2.56
2025
- -
- -
- -
- -
1.19
Similar Companies
Apria, Inc. (APR)
Tobii Dynavox AB (publ) (TDVOX.ST)
Shanghai Conant Optical Co., Ltd. (2276.HK)
HOYA Corporation (HOCPF)
Biotage AB (publ) (BITGF)
Amplitude Surgical S.A. (AMPLI.PA)
Business
EssilorLuxottica S.A. (EL.PA) stands as a global leader in the design, manufacture, and distribution of ophthalmic lenses, eyewear frames, sunglasses, and related vision care products and services. Founded in 2018 through the merger of French lens maker Essilor and Italian eyewear giant Luxottica, the company is headquartered in Charenton-le-Pont near Paris, France, and operates manufacturing plants, distribution centers, and over 18,000 retail stores across more than 150 countries including North America, Europe, Latin America, Asia Pacific, the Middle East, and Africa. Its vertically integrated model spans the entire value chain from research and development to retail, encompassing proprietary lens technologies such as Varilux, Crizal, Eyezen, Transitions, and Xperio; iconic proprietary eyewear brands including Ray-Ban, Oakley, Persol, Oliver Peoples, and Vogue Eyewear; luxury licensed brands like Chanel, Giorgio Armani, Prada, Burberry, Tiffany & Co., and Versace; and major retail chains such as LensCrafters, Sunglass Hut, Pearle Vision, Vision Express, and OPSM, alongside e-commerce platforms and professional equipment from subsidiaries like Essilor Instruments and Heidelberg Engineering. The company serves opticians, eye care professionals, retailers, and consumers targeting visual impairments including myopia, hyperopia, presbyopia, and astigmatism, while expanding into med-tech solutions, smart eyewear, and hearing aids. Recent developments include the 2025 acquisitions of Optegra Eye Health Care clinics across Europe (including brands Iris and Lexum) to bolster ophthalmic services such as cataract surgery and glaucoma treatments, RetinAI for AI-driven eye care data management, and Automation & Robotics for manufacturing advancements; an increased stake in Nikon Corporation to 20% enhancing optical collaborations; the launch of Essilor Stellest 2.0 myopia management lenses and Visioffice X+ AI-powered fitting tools; plans for a new global headquarters in Paris opening in late 2027; and the integration of Supreme brand following its 2024 purchase to reach lifestyle audiences.